s20098 has been researched along with Aura in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, NB; Azim, MS; Vohora, D | 1 |
| Bhutada, PS; Patel, FR; Vimala, PV | 1 |
| Bäuml, J; Förstl, H; Froböse, T; Schreiner, R; Slawik, H; Veselý, Z; Wiegand, M | 1 |
3 other study(ies) available for s20098 and Aura
| Article | Year |
|---|---|
Effects of agomelatine on pentylenetetrazole-induced kindling, kindling-associated oxidative stress, and behavioral despair in mice and modulation of its actions by luzindole and 1-(m-chlorophenyl) piperazine.
Topics: Acetamides; Animals; Anticonvulsants; Antioxidants; Depression; Drug Therapy, Combination; Epilepsy; Hippocampus; Hypnotics and Sedatives; Kindling, Neurologic; Male; Mice; Oxidative Stress; Pentylenetetrazole; Seizures; Treatment Outcome; Tryptamines | 2017 |
Therapeutic potential of agomelatine in epilepsy and epileptic complications.
Topics: Acetamides; Antidepressive Agents; Cell Survival; Circadian Rhythm; Drug Discovery; Epilepsy; Hippocampus; Humans; Melatonin; Models, Biological; Neurogenesis; Receptors, Melatonin; Receptors, Serotonin | 2014 |
Agomelatine improves sleep in a patient with fatal familial insomnia.
Topics: Acetamides; Adult; Epilepsy; Fatal Outcome; Female; Humans; Hypnotics and Sedatives; Insomnia, Fatal Familial; Severity of Illness Index; Sleep Stages; Treatment Outcome | 2012 |